ClinicalTrials.govpublic full text
Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
chronic phase chronic myeloid leukemia, accelerated phase chronic myeloid leukemia, blastic phase chronic myeloid leukemia, philadelphia positive acute lymphoblastic leukemia, resistant to tyrosine kinase inhibitor therapy, tyrosine kinase inhibitor resistance, chronic myeloid leukemia, acute lymphoblastic leukemia, nilotinib, ruxolitinib, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842550
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.